ARA-290 Pre-Mixed Pen 2mg

Description

ARA-290 Pre-Mixed Pen 2mg

Peptide ARA-290 Pre-Mixed Pen , has been shown in clinical studies to reduce HbAl c and improve cholesterol levels, modulate neuropathic pain, stimulate wound repair, and to provide anti-inflammatory properties.

Specifications

Sequence: ZEQLERALNSS

Molecular Formula: C51H84N16O21

Molecular Weight: 1257.3 g/mol

Size: 1 Single mixed cartridge | 2 Pre mixed cartridges | 3 Pre mixed cartridges | Pen kit with 1 pre mixed cartridge

Research

Protection and Tissue Health

Studies using rodents indicate that by decreasing macrophage activation, ARA290 peptide therapy promotes the health and longevity of islet cells in the body. Islet cells regulate blood sugar, and glucose levels better than exogenous insulin, resulting in fewer problems. Although transplanted islet cells do not tolerate well, research indicates that this peptide can extend their longevity.

Investigations have found that the ARA-290 nasal peptide guards against natural inflammatory reactions and enhances tissue protection. Animal studies have shown that this can result in faster wound healing, repair and lower mortality [1].

Preventing Disease

Mice research has demonstrated that ARA-290 nasal can increase the longevity of cells and helps endothelial colony-forming cells (ECFCs) grow and repair blood vessels. Protecting these cells could prevent retinal ischemia which is the leading cause of blindness in western countries [2].

Furthermore, research has indicated that the ARA290 peptide can increase endothelial cell-derived fibroblasts’ migration, growth, and health (ECFCs), explicitly targeting parts of the vasculature that require repair.

In the medical world, ara290 has the potential to play a significant role in the future of protein synthesis, tissue repair, and hormone production.

Immune System Booster

More recently, clinical research has shown that ARA-290 may aid in an immune system boost. Tissue-protective receptor (TPR) is expressed on various immune cells, including mast cells, lymphocytes, dendritic cells, and macrophages.

Based on these scientific findings, ara-290 pre-mixed pen can bind to this TPR on immune cells and alter their activity directly. When ARA 290 increases TPR, it drastically reduces the release of proinflammatory cytokines like IL-6. This activates the innate immune response to prevent illness, or make the symptoms less severe [3].

Pain Relief

Scientists have also suggested that the select IRR (innate repair receptor) can lower inflammation and relieve neuropathic pain. Animal studies show that injecting ARA-290 can decrease the activity of TRPV1 and the IRR. In addition, further studies have demonstrated that by acting this particular receptor, the ARA 290 peptide can alleviate pain caused by or associated with, but not limited to, multiple sclerosis, diabetes and limb amputation.

Treatment with ARA-290 pre-mixed pen can also increase the number of tiny nerve fibres, which often accompany autoimmune illnesses, causing substantial pain reduction. In addition, as a result of research on animals, professionals are confident that a high dose of ARA-290 nasal could be a successful in treating nerve damage caused by disorders such as diabetes, thyroid disease, celiac disease, and HIV [4].

Summary

ARA-290’s unique process of controlling nerve pain has unsurprisingly gained a lot of attention. In addition, the peptide’s immune-modulating properties, it’s capacity to stimulate the repair of wounds, and potential to protect the vasculature during inflammatory reactions have also gathered a lot interest in the medical world. ARA-290’s ability to regulate neuropathic pain is the main focus of most recent studies.

Currently, the peptide is being tested to treat diabetic neuropathy and sarcoid neuropathy. ARA-290 pre-mixed pen is also being tested in laboratory studies to treat systemic lupus erythematosus, multiple sclerosis, HIV, celiac disease, and other chronic conditions that cause pain. In addition, research has suggested patients with inflammatory bowel disease (IBD) are increasingly interested in using ARA-290 as a potential disease-modifying agent.

References

[1] https://pubmed.ncbi.nlm.nih. gov/24555851/

[2] https://pubmed.ncbi.nlm.nih. gov/30876881/

[3] https://www.sciencedirect.com/ science/article/abs/pii/S0196978 116300031

[4] https://www.ncbi.nlm.nih.gov/ pmc/articles/PMC4365069/

Buy ARA-290 Pre-Mixed Pen

Pharma Lab Global is one of the best locations to purchase high purity peptide ARA-290 pre-mixed pen for research use. Pharma Lab Global is a trusted supplier of peptides worldwide. You also have the option to buy ARA-290 peptide vial and ARA-290 nasal spray. Buy from Pharma Lab Global today!

ALL PRODUCT INFORMATION AND ARTICLES ON THIS SITE ARE FOR EDUCATIONAL PURPOSES ONLY

DISCLAIMER: All products sold by Pharma Lab Global are for research and laboratory use only. These products are not designed for use or consumption by humans or animals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such. By purchasing from our Website the buyer accepts and acknowledges the risks involved with handling of these products. All articles and product information provided on this Website are for informational and educational purposes only. Handling and use of these products should be restricted to suitably qualified professionals.